@ProtextP Just to keep my expectations or hopes realistic, when do you think TXTM will break out of its shell? Lots of progress, but I don’t want to have ignorant beliefs. I’ll continue to hold as I have been for years.
I only have $1500 left (my fault) That’s why I ask.
Thank you.
1/
If you’re trying to understand what $TXTM is building — read this.
No hype.
No shortcuts.
Just the full picture.
—
2/
Start here:
$TXTM is currently OTCID.
Meaning:
EDGAR filings are not required.
Now read that again before the next part.
—
3/
Because despite that…
$TXTM established:
• Voluntary EDGAR filing capability
• Broadridge admin infrastructure
• Alignment with EDGAR Next
Above standard. By choice.
—
4/
Then comes the next layer:
Deloitte IRL (Information Request List)
This is where:
Claims → get tested
Numbers → get verified
Value → gets challenged
—
5/
So what you’re seeing is not random activity.
It’s a build sequence:
Transparency → Infrastructure → Validation
That’s how serious companies prepare.
—
6/
Now add real-world drivers:
• FX tailwinds (ZAR/USD)
• Revenue & margin impact
• Strategic roadmap (RWA, APIs, tokenization)
This is multi-layered value creation
—
7/
Here’s the part most miss:
None of this guarantees immediate recognition.
But historically…
This is exactly where asymmetry lives
—
8/
This is what a pre-repricing environment looks like:
• Structure improving
• Risk reducing
• Validation in motion
• Market still catching up
—
9/
No hype needed.
No artificial urgency.
Just a simple truth:
We said we would build.
We are building.
—
10/
$TXTM
Milestone stacking.
Execution compounding.
The more WE, WE are… the more WE are.
Simunye. Ubuntu.
Position accordingly.
Join The Movement !!!
https://t.co/aYZl0k7Vuq
Protext Mobility Inc. $TXTM
Today marks an important evolution for Protext Mobility Inc.
We are proud to launch our new corporate website reflecting the Company’s expanded vision at the intersection of biotechnology, pharmaceutical infrastructure, and digital systems.
Engineering the infrastructure layer between biology, pharmaceutical science & digital capital.
Explore the new platform:
https://t.co/vYgSQaSeVp
Protext Mobility Inc. $TXTM
⏳ Something Significant Is About To Be Unveiled.
Since the challenges that once defined our story, we've remained focused on one thing:
Building.
Building infrastructure.
Building relationships.
Building technology.
Building a foundation for the future.
This week, shareholders will get a closer look at the evolution that has been taking place behind the scenes.
The next chapter of Protext Mobility reflects years of work, strategic development, and a vision that extends far beyond traditional boundaries.
To those who believed in the journey—even when progress wasn't always visible—we see you, and we're grateful.
The road ahead is becoming clearer.
Stay tuned.
⚛️ The beginning of something much bigger.
#TXTM #FutureInfrastructure #Biotechnology #PharmaceuticalScience #DigitalCapital
INSTEAD OF WATCHING NETFLIX TONIGHT.
Spend 1 hour with this.
Claude AI FULL COURSE that teaches you how to BUILD and AUTOMATE anything.
The people who watch this tonight will wake up tomorrow with a new skill.
Watch it and Bookmark it now.
Interesting to see $TXTM showing up on Bitget’s crypto/wiki side now.
This isn’t just another OTC ticker page, Bitget’s overview connects TXTM to botanical/pharma/nutraceutical development, live plant extraction, OTC market visibility, disclosure tracking, and Web3/on-chain research context.
As I’ve said, the bigger story here is where biology, pharmaceutical infrastructure, and digital capital markets start crossing paths.
https://t.co/8e1IT0HMV9
$TXTM
People need to understand what Protext just put out with this new official overview video.
This is not just a random video. It is the company visually explaining the entire infrastructure model behind last Friday’s PR.
Biology → pharmaceutical-grade API development → verification/tokenization → real-world asset infrastructure → digital capital markets.
That is the story.
The video lays out the three pillar framework clearly:
Pillar 1: Biological and agricultural infrastructure
Pillar 2: Proprietary live plant extraction, nanotechnology enhanced processing, and API/pharmaceutical output
Pillar 3: Digital capital, RWA verification, tokenization, and institutional interoperability
The strongest part is the “Live Plant-to-Ledger” engine.
Biological inputs are cultivated, preserved, processed through live plant extraction and nanotechnology, turned into high margin pharmaceutical grade outputs, then verified/tokenized for integration into global digital capital markets.
That is the part people are missing.
This is why the Venezuela LOI is so important.
The company did not just say Dr. J attended an event. They stated he executed a Letter of Intent with the Government of the Bolivarian Republic of Venezuela, tied to biotechnology infrastructure, agricultural development, pharmaceutical initiatives, scientific innovation, and broader infrastructure deployment.
Sit with that for a second.
That is sovereign level infrastructure language.
This is not being framed like a small OTC hemp/product company anymore. Protext is positioning itself as an infrastructure platform across biology, pharma, agriculture, and digital/RWA capital systems.
That changes the scale of the conversation completely.
Yes, execution still matters.
The real catalysts are still the 2024/2025 IFRS audited financials, valuation work, advisory board confirmation, Broadridge investor awareness services, mainnet/digital system details, and the exchange/uplisting path.
But the video matters because it makes the roadmap understandable.
Friday’s PR laid out the framework.
Today’s video made the framework visual.
The Venezuela LOI shows the potential scale.
The market is still trying to value this like a normal OTC story.
The company is describing something much bigger: a biological to digital infrastructure platform built for institutional and sovereign level opportunities.